Thyroidectomy Clinical Trials

Clinical trials related to Thyroidectomy Procedure

The Association Between Bilateral Intermediate Cervical Plexus Block and Salivary and Serum Biomarkers of Surgical Stress Response During Total Thyroidectomy

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The aim of this study is to determine the impact of ultrasound-guided bilateral intermediate cervical plexus block on the surgical stress response in patients undergoing total thyroidectomy, as measured by the concentration of stress and inflammatory biomarkers in the participants' saliva and serum. The study will be conducted on 48 subjects divided into two groups of 24: a control group receiving total intravenous anesthesia (TIVA) and an experimental group receiving TIVA combined with a bilateral intermediate cervical plexus block. Investigators hypothesized that a combination of bilateral intermediate cervical plexus block and total intravenous anesthesia (TIVA) would reduce the surgical stress response, as measured by salivary and blood biomarkers, compared to TIVA alone in patients undergoing total thyroidectomy. Should the research confirm the hypothesis, it will provide an objective scientific argument for including the block in standard anesthetic protocols for total thyroidectomy surgeries, with the ultimate goal of reducing the surgical stress response and ensuring faster patient recovery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• patienets of both sexes

• 18 years of age and older

• ASA I or ASA II

• euthyroid status

• signed informed consent

Locations
Other Locations
Croatia
University Hospital Dubrava
RECRUITING
Zagreb
Contact Information
Primary
Antonija Mihelčić
antonijamihelcic@yahoo.com
+385996830715
Time Frame
Start Date: 2024-05-13
Estimated Completion Date: 2027-08-01
Participants
Target number of participants: 48
Treatments
No_intervention: total intravenous anesthesia (TIVA)
Experimental: TIVA + bilateral intermediate cervical plexus block with 0.25% levobupivacaine
Related Therapeutic Areas
Sponsors
Leads: University Hospital Dubrava

This content was sourced from clinicaltrials.gov